Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OncoMed Pharmaceuticals
Biotech
Newly merged Mereo BioPharma looks to OncoMed for R&D hires
Mereo BioPharma canceled its expected IPO last year in a reverse merger with OncoMed and now is filling up a number of key research posts.
Ben Adams
Jun 30, 2020 8:20am
Closing in on OncoMed reverse merger, Mereo cancels Nasdaq IPO
Feb 22, 2019 10:01am
SITC18: Merck highlights new LAG-3 and TIGIT data
Nov 7, 2018 11:05am
OncoMed shares tank on yet more trial woe; will refocus, review portfolio
Apr 17, 2017 8:54am
OncoMed tanks as phase 2 cancer trial flops and Bayer flees
Apr 10, 2017 9:42am
